Rabinowitz Matthew

Executive Chairman, Director

Avg. Two Year Performance

No Purchase Track Record
(49%) Avg. Sale Return    (22%) Compound

Holdings: 2.15M shares

Last Three Months: 19-Feb-24 -- 18-May-24

($16.69M) Net Amount
Buy:0--
Sell:($16.69M)$87.40 - $88.36

Sentiment

Insider Trading Sentiment: Accumulate

Company Sentiment

Medical Laboratories & Research

Health Services

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions